Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1.
暂无分享,去创建一个
S. Hammer | D. Scadden | J. McGrath | J. Agosti | J. Bresnahan | J. Gere | B. Stretcher | O. Pickus
[1] S. Hammer,et al. In vivo effects of interleukin 3 in HIV type 1-infected patients with cytopenia. , 1995, AIDS research and human retroviruses.
[2] M. Vitale,et al. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. , 1994, Blood.
[3] G. Mufti,et al. Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte macrophage colony stimulating factor. , 1994, Journal of clinical pathology.
[4] E. Brummer,et al. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans , 1994, Antimicrobial Agents and Chemotherapy.
[5] A. Pesce,et al. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity , 1994, AIDS.
[6] L. Bermudez,et al. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. , 1994, The Journal of infectious diseases.
[7] J. Curtis,et al. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. , 1994, Journal of immunology.
[8] R. Calderone,et al. Macrophage interactions with Candida. , 1994, Immunology series.
[9] N. Obel,et al. Phagocytosis and stimulation of the respiratory burst in neutrophils by Pneumocystis carinii. , 1993, The Journal of infectious diseases.
[10] R. Appelberg,et al. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. , 1993, Immunology.
[11] J. Bartolomé,et al. Pilot study of recombinant human granulocyte‐macrophage colony–stimulating factor in the treatment of chronic hepatitis B , 1993, Hepatology.
[12] R. Badaró,et al. Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma , 1993, The Lancet.
[13] M. Goldberg,et al. HIV-1 suppresses erythropoietin production in vitro. , 1993, Experimental hematology.
[14] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.
[15] B. Poiesz,et al. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex , 1993, Antimicrobial Agents and Chemotherapy.
[16] M. Richardson,et al. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[17] A. Sampson,et al. Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy: Overview of Four Clinical Trials , 1992 .
[18] A. Lazzarin,et al. Membrane Expression and Function of Complement Receptors CR1 and CR3 on Neutrophils from HIV‐Infected Subjects: Modulation by rTNF‐α and rGM‐CSF , 1992, Scandinavian journal of immunology.
[19] E. R. Stiehm,et al. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.
[20] A. Foli,et al. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages , 1992 .
[21] N. Flomenberg,et al. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] D. Scadden,et al. Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. , 1992, The Journal of infectious diseases.
[23] G. Bancroft,et al. Cytokine enhancement of complement‐dependent phagocytosis by macrophages: synergy of tumor necrosis factor‐α and granulocyte‐macrophage colony‐stimulating factor for phagocytosis of Cryptococcus neoformans , 1992, European journal of immunology.
[24] D. Golde,et al. Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL‐1, IL‐3, IL‐5 and GM‐CSF , 1992, British journal of haematology.
[25] J. Groopman,et al. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. , 1991, Blood.
[26] M. B. Taylor,et al. The neutrophil chemiluminescence response to Pneumocystis carinii is stimulated by GM-CSF and gamma interferon. , 1991, FEMS microbiology immunology.
[27] A. Athamna,et al. Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures. , 1991, Lymphokine and cytokine research.
[28] J. Metcalf,et al. A Phase I/II Trial of Zidovudine, Interferon-α, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Human Immunodeficiency Virus Type 1 Infection , 1991 .
[29] D. Blanchard,et al. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF , 1991, Infection and immunity.
[30] J. Kahn,et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] G. Baldwin,et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. , 1991, Blood.
[32] D. Scadden,et al. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] T. Merigan,et al. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo , 1991, Journal of virology.
[34] C. Crumpacker,et al. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus , 1991, Journal of virology.
[35] D. Kufe,et al. Effects of granulocyte-macrophage colony-stimulating factor on 3'-azido-3'-deoxythymidine uptake, phosphorylation and nucleotide retention in human U-937 cells. , 1990, Biochemical pharmacology.
[36] D. Scadden,et al. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. , 1990, Blood.
[37] T. Walsh,et al. Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. , 1990, The Journal of pediatrics.
[38] M. Dietrich,et al. CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. , 1990, Blood.
[39] J. Djeu. Role of tumor necrosis factor and colony-stimulating factors in phagocyte function against Candida albicans. , 1990, Diagnostic microbiology and infectious disease.
[40] S. Broder,et al. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. , 1990, Blood.
[41] L. Bermudez,et al. Recombinant Granulocyte–Macrophage Colony‐Stimulating Factor Activates Human Macrophages to Inhibit Growth or Kill Mycobacterium avium Complex , 1990, Journal of leukocyte biology.
[42] S. Banks,et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. , 1990, The Journal of infectious diseases.
[43] S. Hammer,et al. Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages. , 1990, Blood.
[44] N. Yamamoto,et al. Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. , 1989, Biochemical and biophysical research communications.
[45] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[46] D. Scadden,et al. Pathophysiology and management of HIV-associated hematologic disorders. , 1989, Blood.
[47] G. Baldwin,et al. Granulocyte- and granulocyte-macrophage colony-stimulating factors enhance neutrophil cytotoxicity toward HIV-infected cells. , 1989, Blood.
[48] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. S. Webb,et al. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido- 2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine , 1989, The Journal of experimental medicine.
[50] E. Jaffe,et al. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow , 1988, Science.
[51] W. O'brien,et al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. , 1988, Science.
[52] D. Golde,et al. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Justement,et al. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.
[54] M. Greenberg,et al. A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS. , 1987, Blood.
[55] J. Groopman,et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. , 1987, The New England journal of medicine.
[56] A. Ganser,et al. Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. , 1987, The Journal of clinical investigation.
[57] S. Hammer,et al. Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro , 1987, Antimicrobial Agents and Chemotherapy.
[58] J. Groopman,et al. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection , 1987, Nature.
[59] S. Hammer,et al. In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[60] T. Quinn,et al. Hematologic abnormalities in the acquired immune deficiency syndrome. , 1984, The American journal of medicine.
[61] P. Volberding,et al. Hematologic manifestations in homosexual men with Kaposi's sarcoma. , 1984, American journal of clinical pathology.